Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid and postoperative delirium after hip and knee arthroplasty in elderly patients
ChiCTR2500095120Phase 4Not yet recruiting
- Sponsor
- Tai'an City Central Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in postoperative delirium (POD), post-operative cognitive decline (POCD), Bleeding and 1 more (2 arms), sponsored by Tai'an City Central Hospital. Primary endpoint: Incidence of postoperative delirium. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)Bleedingdeep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR2500095120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095120.